MRX1 CBD

N/A

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NameMRX1 CBD
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPainEndometriosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnanda Pharma PLC
China Registration ClassN/A

Develop Information

Active CompaniesAnanda Pharma PLC
Inactive CompaniesN/A
Active IndicationsPainEndometriosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A